Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Report date:
2011

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
3-[(3,4,5-trimethoxyphenyl)methylidene]pentane-2,4-dione
EC Number:
807-059-9
Cas Number:
945558-97-4
Molecular formula:
C15H18O5
IUPAC Name:
3-[(3,4,5-trimethoxyphenyl)methylidene]pentane-2,4-dione

Method

Species / strain
Species / strain / cell type:
S. typhimurium, other: TA97a, TA98, TA100, TA102 and TA1535
Metabolic activation:
with and without
Metabolic activation system:
S-9 activation system
Test concentrations with justification for top dose:
5 mg, 1.6 mg, 0.5 mg, 0.16 mg, 0.05 mg, 0.016 mg/plate
Vehicle / solvent:
DMSO
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
sodium azide
mitomycin C
other: 4-nitro-o- phenylenediamine(NPD), 2-aminofluorene(2-AF), 2- aminoanthracene(2-AA)
Remarks:
NPD and 2-AF for TA97a, sodium azide and 2-AF for TA98, TA100, mitomycin C and 2-AA for TA102, sodium azide and 2-AA for TA1535
Details on test system and experimental conditions:
Three replicates for each test article or control.
Evaluation criteria:
Criteria for a Mutaqen: 1) A greater than two-fold increase in the number of revertants in strains TA97a, TA100 and TA102 or a greater than three-fold increase in strains T A98 and T A 1535 when compared to the solvent control (percent of control >200% or >300%).
2) Demonstration of a clear dose related response when dilutions are tested.
Criteria for a Non-Mutaqen 1) A less than two-fold increase in strains TA97a, TA100 and TA102 or a less than three-fold increase in strains T A98 and T A 1535 when compared to the solvent control (percent of control <200% or <300%)
2) No dose related response when dilutions are tested .

Results and discussion

Test results
Species / strain:
S. typhimurium, other: TA97a, TA98, TA100, TA102 and TA1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
The test article did show some cytotoxicity in all five strains in the higher concentrations, which decreased with the decreasing concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

The test article concentrations did not produce a two-fold or three-fold increase in the number of revertants or produce a clear dose related response in any of the 5 tester strains. The spot tests showed no zone of increased reversion or of toxicity. In summary, the test article concentrations tested against the five strains did not meet the criteria for a potential mutagen.